A CLINICAL STUDY TO ASSESS THE EFFECT OF TRIVRIT TAILA PICHUU AND LAJJALU TAILA PICHUU IN THE MANAGEMENT OF UTERINE PROLAPSE

A RANDOMIZED OPEN LABEL COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF TRIVRIT TAILA PICHUU AND LAJJALU TAILA PICHUU IN THE MANAGEMENT OF PRASRAMSINI YONIVYAPAD W.S.R 1ST AND 2ND DEGREE UTERINE PROLAPSE - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093125

Enrollment

Registered

2025-08-14

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N814- Uterovaginal prolapse, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS HAVING AGE GROUP FROM 30 TO 55 YEARS PATIENTS HAVING FIRST AND SECOND DEGREE UTERINE PROLAPSE PATIENTS HAVING FIRST DEGREE UTERINE PROLAPSE WITH CYSTOCELE OR RECTOCELE PATIENTS HAVING CLINICAL SIGN AND SYMPTOMS OF UTERINE PROLAPSE PATIENTS WILLING TO PARTICIPATE IN TRIAL

Exclusion criteria

Exclusion criteria: PATIENTS BELOW AGE OF 30 YEARS AND ABOVE AGE OF 55 YEARS PATIENTS HAVING THIRD DEGREE UTERINE PROLAPSE PREGNANCY CASES PATIENT HAVING CERVIX AND UTERINE MALIGNANCY PATIENTS HAVING PROCIDENTIA WITH DECUBITUS ULCER OR VAULT PROLAPSE PATIENTS WITH CONGENITAL PROLAPSE OR ELONGATION OF CERVIX PATIENTS HAVING RECTAL PROLAPSE OR PELVIC INFLAMMATORY DISEASE PATIENT PRESENTED WITH KNOWN CASE OF SEXUALLY TRANSMITTED DISEASE FIBROID POLYP

Design outcomes

Secondary

Measure	Time frame
IMPROVEMENT IN SIGN AND SYMPTOMS AND CHANGES IN ASSOCIATED CLINICAL FEATURES RELATED TO UTERINE PROLAPSETimepoint: FOLLOW UP WILL BE DONE ON 8TH 14TH 30TH 38TH 44TH 60TH 68TH 74TH 90TH DAY	—

Primary

Measure	Time frame
IMPROVEMENT IN QUANTITATIVE GRADING OF POP FOR UTERINE PROLAPSETimepoint: FOLLOW UP WILL BE DONE ON 30TH 60TH 90TH DAY	—

Countries

India

Contacts

Public ContactDR NISHU NARWAL

INSTITUTE FOR AYURVED STUDIES AND RESEARCH

drsunititanwar@gmail.com9996311778

Outcome results